# Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis

> **NCT04801433** · NA · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 240 (actual)

## Conditions studied

- Scalp Psoriasis

## Interventions

- **OTHER:** Boleda Supramolecular Active Zinc Conditioner
- **DRUG:** Capotetriol scalp solution
- **OTHER:** Supramolecular Hydrogel

## Key facts

- **NCT ID:** NCT04801433
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-30
- **Primary completion:** 2019-07-04
- **Final completion:** 2019-11-25
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04801433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04801433, "Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04801433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*